Wolverine Blend – BPC-157 (10mg) / TB500 (10mg)
$57.99
14805 in stock
14805 in stock
Share on facebook
Facebook
Share on twitter
X
Share on pinterest
Pinterest
Share on whatsapp
WhatsApp
- This powerful combination of BPC-157 (10mg) and TB500 (10mg) delivers a synergistic approach to tissue repair, inflammation reduction, and accelerated recovery.
- BPC-157, a synthetic peptide derived from the body protection compound, is recognized for its ability to speed up wound healing, support joint integrity, and aid in gastrointestinal repair.
- TB500, a synthetic version of thymosin beta-4, promotes cell migration, new blood vessel formation (angiogenesis), and collagen production, making it highly effective for muscle healing and enhanced flexibility.
- Together, these peptides work to improve soft tissue regeneration, shorten recovery periods, and deliver broad anti-inflammatory support—making the blend ideal for recovery from injury, surgery, or high physical demand.
- This formulation is well-suited for researchers and experienced users focused on maximizing recovery, supporting musculoskeletal health, and enhancing physical performance safely and effectively.
Related Products
SUBSCRIBE & SAVE
Sign up below and be the first to know about new products and upcoming promotions!
CONTACT INFO
Quick links
SHIPPING DAYS
Monday to Friday Expect 48 hours for order processing and 7 days (or more) for delivery
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.
All products are sold in powder (lyophilized) form and require reconstitution with a suitable diluent. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
Reviews
There are no reviews yet.